Erlotinib hydrochlorideProduct ingredient for Erlotinib

Name
Erlotinib hydrochloride
Drug (Active Moiety)
Erlotinib

Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer.

Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders.

Accession Number
DBSALT000064
Structure
Thumb
Synonyms
Erlotinib HCl
UNII
DA87705X9K
CAS Number
183319-69-9
Weight
Average: 429.897
Monoisotopic: 429.145533978
Chemical Formula
C22H24ClN3O4
InChI Key
GTTBEUCJPZQMDZ-UHFFFAOYSA-N
InChI
InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H
IUPAC Name
SMILES
[H+].[Cl-].COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
External Links
KEGG Drug
D04023
PubChem Compound
176871
ChemSpider
154045
ChEBI
53509
ChEMBL
CHEMBL1079742
Wikipedia
Erlotinib
Predicted Properties
PropertyValueSource